SCHEMBL8868396

SCHEMBL8868396

O=C(Cc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.54
HDAC1 Q13547 3/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC4 P56524 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
P4HTM Q9NXG6 5/20 0.54
SCN3A Q9NY46 1/20 0.50
PRMT1 Q99873 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CA5B Q9Y2D0 1/20 0.47
LMNA P02545 2/20 0.47
BCL2 P10415 1/20 0.47
BCL2L1 Q07817 1/20 0.47
MCL1 Q07820 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868481 0.91 HDAC3 (0.51) HDAC3HDAC1HDAC8HDAC4HDAC6
SCHEMBL8869119 0.91 L3MBTL1 (0.56) HDAC1P4HTMPRMT1BCL2BCL2L1
SCHEMBL8869732 0.88 P4HTM (0.53) P4HTMCA12CA1CA2CA5A
SCHEMBL8870946 0.87 ALDH1A1 (0.55) P4HTMALDH1A1MEN1KMT2APOLB
SCHEMBL7870480 0.86 SCN3A (0.46) HDAC3HDAC1HDAC8HDAC4HDAC6
SCHEMBL8868261 0.86 P4HTM (0.49) P4HTMCA12CA1CA2CA9
SCHEMBL8867590 0.85 P4HTM (0.72) P4HTMKDM4ENPC1RAB9AALDH1A1
SCHEMBL9143209 0.85 RAB9A (0.57) HDAC3HDAC1HDAC8HDAC4HDAC6
SCHEMBL8868551 0.84 P4HTM (0.47) P4HTMCA12CA1CA2CA9
SCHEMBL8869159 0.84 P4HTM (0.58) HDAC8HDAC6P4HTMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed